🔴 HCW Biologics is trading 6.7% down as oil and bond yields revived inflation concerns

HCW Biologics is trading at $1.80, down 6.74%, amid broader risk-off pressure.

• Reuters reported September 28 that shares were mostly lower as rising oil prices and bond yields revived inflation concerns.
• Supplied market data showed the Dow down 0.62% and Nasdaq down 0.51%.
• HCW Biologics’ September 24 $1.5 million private placement remains relevant financing context, but available reporting does not establish it as the direct cause of this session’s decline. No new company-specific announcement was found for September 28.